134 related articles for article (PubMed ID: 20336771)
21. MDA-7/IL-24, a novel tumor suppressor/cytokine is ubiquitinated and regulated by the ubiquitin-proteasome system, and inhibition of MDA-7/IL-24 degradation enhances the antitumor activity.
Gopalan B; Shanker M; Scott A; Branch CD; Chada S; Ramesh R
Cancer Gene Ther; 2008 Jan; 15(1):1-8. PubMed ID: 17828282
[TBL] [Abstract][Full Text] [Related]
22. The proteasome in Alzheimer's disease and Parkinson's disease: lessons from ubiquitin B+1.
Hol EM; van Leeuwen FW; Fischer DF
Trends Mol Med; 2005 Nov; 11(11):488-95. PubMed ID: 16213790
[TBL] [Abstract][Full Text] [Related]
23. Review: unchained maladie - a reassessment of the role of Ubb(+1) -capped polyubiquitin chains in Alzheimer's disease.
Chadwick L; Gentle L; Strachan J; Layfield R
Neuropathol Appl Neurobiol; 2012 Apr; 38(2):118-31. PubMed ID: 22082077
[TBL] [Abstract][Full Text] [Related]
24. Mutant ubiquitin found in Alzheimer's disease causes neuritic beading of mitochondria in association with neuronal degeneration.
Tan Z; Sun X; Hou FS; Oh HW; Hilgenberg LG; Hol EM; van Leeuwen FW; Smith MA; O'Dowd DK; Schreiber SS
Cell Death Differ; 2007 Oct; 14(10):1721-32. PubMed ID: 17571083
[TBL] [Abstract][Full Text] [Related]
25. The nuclear ubiquitin-proteasome system: visualization of proteasomes, protein aggregates, and proteolysis in the cell nucleus.
von Mikecz A; Chen M; Rockel T; Scharf A
Methods Mol Biol; 2008; 463():191-202. PubMed ID: 18951170
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of clusterin/apolipoprotein J in lactacystin-treated SH-SY5Y cells.
Carreras I; Garrett-Young R; Ullman MD; Eisenhauer PB; Fine RE; Wells JM; Conn KJ
J Neurosci Res; 2005 Feb; 79(4):495-502. PubMed ID: 15635600
[TBL] [Abstract][Full Text] [Related]
27. Proteasome subunit proteins and neuropathology in tauopathies and synucleinopathies: Consequences for proteomic analyses.
Zouambia M; Fischer DF; Hobo B; De Vos RA; Hol EM; Varndell IM; Sheppard PW; Van Leeuwen FW
Proteomics; 2008 Mar; 8(6):1221-36. PubMed ID: 18283660
[TBL] [Abstract][Full Text] [Related]
28. Impaired proteasome activity and accumulation of ubiquitinated substrates in a hereditary neuropathy model.
Fortun J; Li J; Go J; Fenstermaker A; Fletcher BS; Notterpek L
J Neurochem; 2005 Mar; 92(6):1531-41. PubMed ID: 15748170
[TBL] [Abstract][Full Text] [Related]
29. Changes in three types of ubiquitin mRNA and ubiquitin-protein conjugate levels during lens development.
Yang S; Wang-Su ST; Cai H; Wagner BJ
Exp Eye Res; 2002 May; 74(5):595-604. PubMed ID: 12076081
[TBL] [Abstract][Full Text] [Related]
30. Phosphorylation of serine 188 protects RhoA from ubiquitin/proteasome-mediated degradation in vascular smooth muscle cells.
Rolli-Derkinderen M; Sauzeau V; Boyer L; Lemichez E; Baron C; Henrion D; Loirand G; Pacaud P
Circ Res; 2005 Jun; 96(11):1152-60. PubMed ID: 15890975
[TBL] [Abstract][Full Text] [Related]
31. Preservation of caspase-3 subunits from degradation contributes to apoptosis evoked by lactacystin: any single lysine or lysine pair of the small subunit is sufficient for ubiquitination.
Chen L; Smith L; Wang Z; Smith JB
Mol Pharmacol; 2003 Aug; 64(2):334-45. PubMed ID: 12869638
[TBL] [Abstract][Full Text] [Related]
32. Proteasome inhibitor lactacystin disturbs the intracellular calcium homeostasis of dopamine neurons in ventral mesencephalic cultures.
Li X; Yang D; Li L; Peng C; Chen S; Le W
Neurochem Int; 2007 Jun; 50(7-8):959-65. PubMed ID: 17561309
[TBL] [Abstract][Full Text] [Related]
33. Effect of ubiquitin-proteasome pathway on mouse blastocyst implantation and expression of matrix metalloproteinases-2 and -9.
Wang HM; Zhang X; Qian D; Lin HY; Li QL; Liu DL; Liu GY; Yu XD; Zhu C
Biol Reprod; 2004 Feb; 70(2):481-7. PubMed ID: 14561647
[TBL] [Abstract][Full Text] [Related]
34. Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation.
Lindsten K; de Vrij FM; Verhoef LG; Fischer DF; van Leeuwen FW; Hol EM; Masucci MG; Dantuma NP
J Cell Biol; 2002 Apr; 157(3):417-27. PubMed ID: 11980917
[TBL] [Abstract][Full Text] [Related]
35. Tau is not normally degraded by the proteasome.
Feuillette S; Blard O; Lecourtois M; Frébourg T; Campion D; Dumanchin C
J Neurosci Res; 2005 May; 80(3):400-5. PubMed ID: 15795929
[TBL] [Abstract][Full Text] [Related]
36. Knocking out ubiquitin proteasome system function in vivo and in vitro with genetically encodable tandem ubiquitin.
Saeki Y; Isono E; Shimada M; Kawahara H; Yokosawa H; Toh-E A
Methods Enzymol; 2005; 399():64-74. PubMed ID: 16338349
[TBL] [Abstract][Full Text] [Related]
37. 17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse.
Tokui K; Adachi H; Waza M; Katsuno M; Minamiyama M; Doi H; Tanaka K; Hamazaki J; Murata S; Tanaka F; Sobue G
Hum Mol Genet; 2009 Mar; 18(5):898-910. PubMed ID: 19066230
[TBL] [Abstract][Full Text] [Related]
38. The mechanism of cytokeratin aggresome formation: the role of mutant ubiquitin (UBB+1).
Bardag-Gorce F; Riley N; Nguyen V; Montgomery RO; French BA; Li J; van Leeuwen FW; Lungo W; McPhaul LW; French SW
Exp Mol Pathol; 2003 Apr; 74(2):160-7. PubMed ID: 12710947
[TBL] [Abstract][Full Text] [Related]
39. Disease-associated mutant ubiquitin causes proteasomal impairment and enhances the toxicity of protein aggregates.
Tank EM; True HL
PLoS Genet; 2009 Feb; 5(2):e1000382. PubMed ID: 19214209
[TBL] [Abstract][Full Text] [Related]
40. Mutant ubiquitin UBB+1 induces mitochondrial fusion by destabilizing mitochondrial fission-specific proteins and confers resistance to oxidative stress-induced cell death in astrocytic cells.
Yim N; Ryu SW; Han EC; Yoon J; Choi K; Choi C
PLoS One; 2014; 9(6):e99937. PubMed ID: 24941066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
